Astellas Ireland Co., Ltd.
PolandAll drugs from this manufacturer
-
The medicine is used to control the immune system response after organ transplantation (e.g., liver, kidney, or heart) to prevent rejection. It may also be used in cases of transplanted organ rejection or when previous treatment has not been effective.
Dosage form: solution for infusion, concentrate
Active substance Dosage tacrolimus 5 mg ATC: L04AD02
-
The medicine is used to control the immune system response after organ transplantation (e.g., liver, kidney, or heart) to prevent rejection. It may also be used in cases of transplanted organ rejection or when previous treatment has not been effective.
Dosage form: capsules, hard
Active substance Dosage tacrolimus 5 mg ATC: L04AD02
-
The medicine is used to control the immune system response after organ transplantation (e.g., liver, kidney, or heart) to prevent rejection. It may also be used when previous treatment has not been effective or when there is a risk of rejection of the transplanted organ.
Dosage form: capsules
Active substance Dosage tacrolimus 0.5 mg ATC: L04AD02
-
The medicine is used to control the immune system response after organ transplantation (e.g., liver, kidney, or heart) to prevent rejection. It may also be used when previous treatment has not been effective or in cases of risk of transplanted organ rejection.
Dosage form: capsules, hard
Active substance Dosage tacrolimus 1 mg ATC: L04AD02